vimarsana.com

Advanced Optical Sensors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ams Innovation in Medical Sensing Technology Recognized With Three Elektra Award Nominations

ams Innovation in Medical Sensing Technology Recognized With Three Elektra Award Nominations ams (SIX: AMS), a leading worldwide supplier of high performance sensor solutions, announces that it is shortlisted for three Elektra awards in recognition of recent breakthroughs made by the company in medical sensing technology. Two ams optical sensors have separately been shortlisted for the Award for Excellence in Product Design (Medical), while the company s Advanced Optical Sensors division is shortlisted in the Award for Design Team of the Year. Used in point-of-care and wearable-device applications, they make an important contribution to Covid-19 (SARS-CoV-2) pandemic control and blood oxygen saturation monitoring. Winners of the UK s prestigious Elektra awards (www.elektraawards.co.uk/), hosted by Electronics Weekly, are due to be announced on 25 March.

ams and Precision Biomonitoring to develop saliva antigen tester for Covid-19

ams and Precision Biomonitoring to develop saliva antigen tester for Covid-19 29 Dec 2020 Based on ams s spectral sensors and PB s virus detection capabilities to enable “swift and conclusive test results.” The partnership will see ams’ innovative spectral sensor technology paired with Precision Biomonitoring’s lateral flow and digital capabilities. The combination is expected to re-imagine mass testing devices for Covid-19. Initial results, on inactivated virus particles, “indicate a very good sensitivity in the order of cycle time (CT) 31, which could lead to the identification of asymptomatic persons,” say the partners. Dr. Mario Thomas, CEO, Precision Biomonitoring, commented, “The pandemic will continue to be part of our lives well into the new year. This partnership with ams will continue to provide innovative solutions urgently needed by government and authorities to help track and control this virus.

ams and Precision Biomonitoring announce global partnership to enable pandemic control through the development of a rapid saliva antigen testing device for Covid-19 (SARS-CoV-2)

ams and Precision Biomonitoring announce global partnership to enable pandemic control through the development of a rapid saliva antigen testing device for Covid-19 (SARS-CoV-2)
businesswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesswire.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.